SKU(재고 관리 코드):LMF293Ra
Magnetic Luminex Assay Kit for Claudin 3 (CLDN3) ,etc.
Magnetic Luminex Assay Kit for Claudin 3 (CLDN3) ,etc.
Product No.
LMF293Ra
Organism Species
Rattus norvegicus (Rat).
Sample Type
Tissue homogenates, cell lysates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
0.01-10ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.003 ng/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Claudin 3 (CLDN3) ,etc..
No significant cross-reactivity or interference between Claudin 3 (CLDN3) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Claudin 3 (CLDN3) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Claudin 3 (CLDN3) ,etc. in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 97-105 | 101 |
EDTA plasma(n=5) | 84-102 | 89 |
heparin plasma(n=5) | 86-93 | 89 |
sodium citrate plasma(n=5) | 83-91 | 87 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Claudin 3 (CLDN3) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Claudin 3 (CLDN3) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Claudin 3 (CLDN3) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 79-90% | 81-97% | 82-93% | 80-96% |
EDTA plasma(n=5) | 86-95% | 85-96% | 88-95% | 95-104% |
heparin plasma(n=5) | 85-101% | 97-105% | 78-103% | 79-94% |
sodium citrate plasma(n=5) | 88-96% | 91-103% | 79-90% | 79-103% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:CLDN3) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
Magazine | Citations |
Eur J Appl Physiol | Gastrointestinal response and endotoxemia during intense exercise in hot and cool environments Pubmed: 23314685 |
European Journal of Applied Physiology | Effects of probiotics supplementation on gastrointestinal permeability, inflammation and exercise performance in the heat Springer: Source |
Pediatr Crit Care Med | Clinical Characteristics Associated With Postoperative Intestinal Epithelial Barrier Dysfunction in Children With Congenital Heart Disease* PubMed: 25162512 |
Clinical Nutrition | Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial: Arabinoxylans in gut barrier. pubmed:28214040 |
Clinics and Research in Hepatology and Gastroenterology | Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease Pubmed: 31053499 |
Nutrients | Intestinal Permeability in Children with Celiac Disease after the Administration of Oligofructose-Enriched Inulin into a Gluten-Free Diet—Results of a Randomized … Pubmed: 32531982 |
Journal of Exercise Physiology Online | Markers of Intestinal Damage in Individuals with and without Obesity during a 12-Week Exercise Period. |
JACC: Basic to Translational Science | Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease is Exacerbated Following Cardiopulmonary Bypass |
Nutrients | Short-Term Very High Carbohydrate Diet and Gut-Training Have Minor Effects on Gastrointestinal Status and Performance in Highly Trained Endurance Athletes Pubmed:35565896 |
Catalog No. | Related products for research use of Rattus norvegicus (Rat) Organism species | Applications (RESEARCH USE ONLY!) |
RPF293Ra01 | Recombinant Claudin 3 (CLDN3) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAF293Ra01 | Polyclonal Antibody to Claudin 3 (CLDN3) | WB; IHC; ICC; IP. |
MAF293Ra21 | Monoclonal Antibody to Claudin 3 (CLDN3) | WB; IHC; ICC; IP. |
SEF293Ra | ELISA Kit for Claudin 3 (CLDN3) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMF293Ra | Magnetic Luminex Assay Kit for Claudin 3 (CLDN3) ,etc. | Magnetic Luminex Assay for Antigen Detection. |